NFL Hall of Famer Brett Favre Reports Significant Parkinson's Medication Reduction as Zhittya Genesis Medicine Marks Four Years of Parkinson’s Research
By Zhittya Genesis Medicine Inc••GlobeNewswire
Brett Favre posted that he is being treated with Zhittya Genesis Medicine Inc FGF-1 in a Medical Research Study on X to improve his Parkinson's disease...
LAS VEGAS, May 14, 2026 (GLOBE NEWSWIRE) -- As Zhittya Genesis Medicine, Inc., a Nevada-based biopharmaceutical company developing recombinant human Fibroblast Growth Factor-1 (FGF-1) therapies, mark…